Tag: anavex life sciences

June 25, 2019

Anavex Life Sciences Doses First Patient in Extension Study to US Phase 2 Clinical Trial of ANAVEX2-73

Anavex Life Sciences (NASDAQ:AVXL) has announced that the first patient that completed the Phase 2 clinical trial ANAVEX2-73-RS-001 has moved...
June 6, 2019

Anavex Life Sciences Doses First Patient in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndrome

Anavex Life Sciences (NASDAQ:AVXL) has announced it has dosed its first patient in its AVATAR Phase 2 trial of ANAVEX2-73...
March 10, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Dips 6 Percent

Proteon Therapeutics, Chiasma, Vermillion, Anavex Life Sciences and Foamix Pharmaceuticals were last week's top gainers.
October 19, 2018

Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX2-73

Anavex Life Sciences (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including...
July 9, 2018

Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson’s Disease Dementia

Anavex Life Sciences (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, today...
July 3, 2018

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX 2-73 for the Treatment of Early Alzheimer’s Disease

Anavex Life Sciences (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including...